GSK plc (GSK) - Financials, balance sheet (annual)

1,449.5 GBP

13.5

0.92%

Last update May 2, 4:29 PM BST

Market closed

Day range

1,449.5

1,447

1,478.5

Previous close

1,463

Open

1,450

Access this stock data via API

GSK plc

1,449.50

13.50

0.92%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	59.5B	59.0B	60.1B	79.1B
Current assets	17.0B	18.6B	20.8B	18.7B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	3.7B	2.7B	3.5B	4.1B
Other short term investments	21M	2.2B	4.2B	61M
Accounts receivable	5.6B	5.9B	5.5B	6.2B
Other receivables	436M	560M	766M	1.3B
Inventory	5.7B	5.5B	5.1B	5.8B
Prepaid assets	390M	355M	343M	315M
Restricted cash	177M	190M	200M	200M
Assets held for sale	3M	76M	98M	22M
Hedging assets	109M	130M	190M	188M
Other current assets	—	—	—	—
Non current assets	42.5B	40.4B	39.4B	60.4B
Properties	8M	4M	6M	9M
Land and improvements	6.4B	6.5B	6.6B	7.2B
Machinery furniture equipment	11.2B	10.9B	11.1B	11.9B
Construction in progress	2.3B	2.1B	1.9B	1.8B
Leases	—	—	—	—
Accumulated depreciation	-10.5B	-10.3B	-10.5B	-10.8B
Goodwill	29.5B	28.4B	28.4B	51.2B
Investment properties	—	—	—	—
Financial assets	1M	—	0	18M
Intangible assets	15.5B	14.8B	14.3B	30.1B
Investments and advances	—	—	—	—
Other non current assets	—	—	—	—
Total liabilities	46.4B	46.2B	50.1B	57.8B
Current liabilities	21.7B	21.1B	22.8B	23.7B
Accounts payable	3.5B	3.7B	3.9B	4.5B
Accrued expenses	—	—	—	—
Short term debt	2.3B	2.8B	4.0B	3.6B
Deferred revenue	—	—	—	—
Tax payable	703M	500M	471M	489M
Pensions	125M	126M	126M	152M
Other current liabilities	1.2B	1.1B	1.3B	958M
Non current liabilities	24.7B	25.1B	27.2B	34.1B
Long term provisions	589M	495M	532M	630M
Long term debt	14.6B	15.2B	17.0B	20.6B
Provision for risks and charges	929M	924M	932M	1.0B
Deferred liabilities	382M	311M	289M	3.6B
Derivative product liabilities	—	—	0	1M
Other non current liabilities	6.1B	5.6B	5.8B	5.1B
Shareholders equity
Common stock	1.3B	1.3B	1.3B	1.3B
Retained earnings	7.8B	7.2B	4.4B	7.9B
Other shareholders equity	—	—	—	—
Total shareholders equity	13.1B	12.8B	10.1B	21.3B
Additional paid in capital	3.5B	3.5B	3.4B	3.3B
Treasury stock	—	—	—	—
Minority interest	-585M	-552M	-502M	6.3B